165 Aufrufe 165 0 Kommentare 0 Kommentare

    Single-use Bioprocessing Market worth US$33.67 billion by 2030 with 13.3% CAGR | MarketsandMarkets.

    DELRAY BEACH, Fla., Oct. 10, 2025 /PRNewswire/ -- The global Single-use Bioprocessing Market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.67 billion by the end of the period. Some factors contributing to the growth of the global single-use bioprocessing market include the growing adoption among contract development & manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs), the increased productivity, and the reduced risk of cross-contamination. Moreover, reduced capital investment and the thriving biologics & biosimilar markets bolster the market growth.

    MarketsandMarkets_Logo

    Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Merck KGaA!
    Long
    109,62€
    Basispreis
    0,86
    Ask
    × 13,74
    Hebel
    Zum Produkt
    Blatt
    Short
    125,70€
    Basispreis
    0,87
    Ask
    × 13,58
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Browse in-depth TOC on "Single Use Bioprocessing Market"

    740 - Tables
    65 - Figures
    570 - Pages

    Based on region, the single-use bioprocessing market is segmented into six major regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America dominated the single-use bioprocessing market. Significant spending on pharmaceutical R&D activities, increasing demand for biosimilars, significant investments by biopharmaceutical companies & CMOs, a well-established healthcare market, and robust biopharmaceutical R&D infrastructure contribute to the large share of the North America market. Moreover, the US held the largest share in the North American market, as the country is the world's largest biopharmaceutical market and a leader in biopharmaceutical research & investments. Such increasing focus on biopharmaceutical manufacturing and the need for safe & high-quality products are expected to boost the demand for single-use bioprocessing products in the country.

    By product, the single-use bioprocessing market is segmented into equipment and consumables. The consumables segment is projected to grow at the highest CAGR during the forecast period. This can be attributed to their repeated purchase, higher usage, frequent replacement, and broad application range. Additionally, the rising adoption of single-use technologies to minimize cross-contamination risks and improve process efficiency further augments the demand for consumables.

    Seite 1 von 3 




    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    16 im Artikel enthaltene WerteIm Artikel enthaltene Werte
    Single-use Bioprocessing Market worth US$33.67 billion by 2030 with 13.3% CAGR | MarketsandMarkets. DELRAY BEACH, Fla., Oct. 10, 2025 /PRNewswire/ - The global Single-use Bioprocessing Market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2025 to 2030, …